The orally administered para-amino benzoic acid (PABA) is known to have near 100% excretion in urine and is used as a measure of 24-h urine collection completeness (referred to as PABAcheck). The purpose was to examine the effect of including urine collections deemed incomplete based on PABAcheck in a dietary measurement error study. SUBJECTS/METHODS: The Observing Protein and Energy Nutrition (OPEN) study was conducted in 1999-2000 and included 484 men and women aged 40-69 years. A food frequency questionnaire and 24-h dietary recalls were evaluated using recovery biomarkers that included urinary nitrogen and potassium from two 24-h urine collections. Statistical modeling determined the measurement error properties of dietary assessment instruments. In the original analyses, PABAcheck was used as a measure of complete urine collection; incomplete collections were either excluded or adjusted to acceptable levels. The OPEN data were reanalyzed including all urine collections and by using criteria based on self-reported missing voids to assess the differences. RESULTS: Means and coefficients of variation for biomarker-based protein and potassium intakes, and measurement error modelbased correlations and attenuation factors were similar regardless of whether PABAcheck or missed voids were considered. CONCLUSION: PABAcheck may not be required in large population-based biomarker studies. However, until there are more analyses evaluating the necessity of a PABAcheck, it is recommended that PABA be given to all participants, but not necessarily analyzed. Then, PABAcheck could be used selectively as a marker of completeness among the collections in which low levels of biomarker are detected or for which noncompliance is suspected.
INTRODUCTION
Objective biomarkers are useful to validate self-reported dietary assessment instruments. However, only a few biomarkers, defined as 'recovery' biomarkers, have a consistent relationship with the amount consumed at the level of the individual 1,2 among individuals who are weight-stable and not experiencing illness or trauma. Among these are doubly labeled water (DLW), a recovery marker for energy intake and nitrogen and potassium from 24-h urine collections. 'Concentration' biomarkers (for example, serum carotenoids, serum vitamin C) are related to dietary intakes, but unlike recovery biomarkers, they cannot be used to evaluate self-reported intakes in the same way, because their levels vary based on personal characteristics and other variations in metabolism. 1 In the 1970s and 80s, Huse et al. 3 and Isaksson 4 proposed the use of 24-h urinary nitrogen to assess the accuracy of self-reported dietary protein intakes, using controlled feeding studies to show utility. Subsequently, Bingham and Cummings 5 conducted a 28-day metabolic study in which daily dietary intakes were measured and daily 24-h urine was collected, both of which were later analyzed for nitrogen content. Urinary nitrogen output averaged 81±5% of nitrogen intake with little variation across subjects. This ratio of urinary to dietary nitrogen has since been used in multiple large free-living studies to assess the error in reporting protein in dietary assessment instruments. [6] [7] [8] [9] [10] A recent metabolic study also confirmed the use of 24-h urinary potassium as a recovery biomarker, indicating that the range of dietary potassium recovery in urine is similar to that in nitrogen (B80%). 11 An important issue in the conduct of any study requiring 24-h urine is collection completeness. Bingham and Cummings 12 pioneered the use of 80-mg pills of para-amino benzoic acid (PABA) taken orally three times on collection days as a check of completeness (referred to as the PABAcheck method). Their research showed that most subjects excreted490% of PABA in urine 5 h post ingestion (range ¼ 15%), indicating that PABA provides an assessment of completeness. It was recommended that collections containing o85% PABA be classified as unsatisfactory. The method was later verified by Roberts et al., 13 though two studies indicate that PABA excretion declines with age due to delayed renal clearance, 14, 15 leading to the possibility that complete urine collections will be falsely rejected for older subjects.
This analysis was undertaken as a result of an ongoing effort to pool the data from four large dietary biomarker studies conducted in the United States 6, 8, 9, 16 in which PABAcheck was not universally employed. There were concerns that without PABAcheck the data quality would be compromised. The Observing Protein and Energy 1 (OPEN) study employed PABAcheck urinary collection exclusions for all analyses of urinary nitrogen and potassium. To assess the effect of such exclusions, the OPEN data were reanalyzed comparing mean biomarker-based nitrogen and potassium values and measurement error model results with or without employing the PABAcheck method and based on PABAcheck versus categories of self-reported missed voids.
SUBJECTS AND METHODS
The OPEN Study is described in detail elsewhere. 6 The primary goal of the study was to describe the measurement error structure of a food frequency questionnaire (FFQ) and 24-h dietary recalls (24HRs). 7 Participants were 484 men and women aged 40-69 years recruited from a random sample of 5000 households in the Washington, DC metropolitan area. Fifty-eight percent of eligible participants agreed to participate in the study; only two participants dropped out during the course of the study. The National Cancer Institute's (NCI) Special Studies Institutional Review Board approved the study. Participants in the OPEN Study completed three clinic visits over a period of approximately 3 months between September 1999 and March 2000. Participants were fairly and evenly distributed by decade of age and sex. Most were non-Hispanic white (86.1%) and college educated or above (91.6%).
Study activities
Participants completed both an FFQ and a 24HR twice, at visits 1 and 3, approximately 3 months apart. The FFQ used was the National Cancer Institute's Diet History Questionnaire (http://riskfactor.cancer.gov/DHQ), which had previously been validated. 17 It was mailed to participants approximately 2 weeks before visits 1 and 3 to complete and return at the clinic visit, where it was reviewed. Also, at visits 1 and 3, trained interviewers administered the 24HR using a standardized five-pass method developed by the US Department of Agriculture. 18 The 24HR data were analyzed using the Food Intake Analysis System (version 3.99). Participants received their DLW dose at visit 1 and returned for visit 2 two weeks later to complete the DLW assessment. A subset of 25 participants was dosed with DLW a second time to determine the error variance for DLW. Participants provided two 24-h urine collections during the 2-week period between visit 1 and visit 2, which was verified for completeness by using the PABAcheck method. 12 
24-h urine collections
Participants received written and verbal instructions on how to collect 24-h urine and take para-amino benzoic acid tablets (PABA; PABAcheck, Laboratories for Applied Biology, London, UK). On the first morning of collection, participants were asked to discard their first urine specimen and to collect all specimens for the next 24 h, up to and including the first urine specimen of the next day. To verify completeness, participants were instructed to take one of three 80-mg PABA tablets first, after discarding their first morning void, and then again at the time of lunch and dinner. During each collection period, participants recorded (1) time of start and finish of urine collection, (2) whether PABA tablets were taken, (3) time PABA tablets were taken, (4) missed voids, and (5) medications/ supplements taken. If a participant reported missing any voids (yes/no), they were asked to record the time of the missed collection and to estimate the amount missed in ounces. Participants were asked to eat and drink normally. All 24-h urine samples were mixed and weighed before aliquoting into two 25-ml glass bottles. Samples were stored at 20 1C until further analysis. All urine collections were aliquoted within 1 day of completion. Urine PABA concentrations were measured in duplicate by the colorimetric technique. 19 Collections with less than 70% PABA recovery were considered incomplete and removed from further analyses, 12 whereas samples containing 70-85% PABA were included in the analyses, but the quantities of analytes were proportionally adjusted to 93% PABA recovery. 20 When drugs such as acetaminophen and sulfonamides are taken, they are known to lead to a false value of 4110% PABA recovery by the colorimetric method. 21 Therefore, all samples in excess of 110% recovery by the colorimetric technique (n ¼ 123) were analyzed by high-performance liquid chromatography (HPLC), 22 a method that can distinguish between PABA and other medications. A Phenomenex Luna 5 m C18 Column was used; mobile phase of 15% acetonitrile, 85% 0.02 M potassium dihydrogen orthophosphate buffer at a flow rate of 1 ml/min; and UV detection at a wavelength of 290 nm. The PABA retention time was 7.5 min and the internal standard (3-hydroxybenzoic acid) was 12.5 min. In the absence of agreed cut-offs for completeness of urine when using HPLC, samples with less than 78% recovery were excluded as suggested elsewhere. 22 Samples with greater than 110%, clear outliers, were also excluded.
Total urinary nitrogen (UN) was measured by the Kjeldahl technique (Tecator 1015 digestor and Kjeltec 1035 analyser, Foss UK, York, UK). Urinary potassium was measured by flame photometry (IL 943, Instrumentation Lab., Warrington, Cheshire, UK).
As approximately 81% of nitrogen intake is excreted through urine 5 and nitrogen constitutes 16% of protein, the urinary nitrogen values were divided by 0.81 and multiplied by 6.25 to estimate the individual protein intake. Values for urinary potassium were divided by 0.80 to estimate the individual potassium intake, assuming 80% of potassium intake is recovered in urine. 23 
Analyses
In previous analyses of the OPEN study, one of a descriptive nature 6 and four that used statistical modeling to assess the measurement error structure of self-reported dietary intakes of protein and potassium, 7, [24] [25] [26] PABAcheck was used to exclude and adjust urinary biomarker data, as described above. In the present analysis, we compare five methods for excluding and adjusting urinary data: (1) using PABAcheck to exclude and adjust data; (2) using PABAcheck to exclude but not adjust data; (3) excluding data based on self-report of any missing voids; (4) excluding data based on self-report of missing more than one void; (5) no exclusions.
For each exclusion/adjustment method, we calculated the geometric means and coefficients of variation for the biomarker-based estimates of four nutrients: protein (g/d), protein density (% energy from protein), potassium (mg/d), and potassium density (mg/1000 kcal), using DLW determinations to determine the energy intake for the calculation of densities. Assuming an approximately lognormal distribution, we calculated the coefficient of variation of each measure as (exp(s , where s 2 is the variance of the biomarker measure on the log scale. We also estimated the correlations of true and self-reported intakes (measured on the log scale) and the attenuation factors (slopes in the regression of log true intake on log self-reported intake) for the FFQ-and 24HR-based estimates of these four nutrients. For protein and potassium, the correlations and attenuation factors were estimated using the measurement error model described in Kipnis et al. 7 For protein and potassium densities, they were estimated using the bivariate (nutrient and energy) model described in Carroll et al.
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RESULTS AND DISCUSSION
Of 941 total 24-h urine collections, 93 (10%) contained almost no PABA, the result of participants forgetting or refusing (because they did not want to take pills of any kind or claimed to be allergic to PABA) to take the tablets. For all other collections, urinary PABA was present. Table 1 shows the number of urine collections acceptable by PABAcheck, by categorization of self-reported missed voids and with no exclusions. As expected, use of PABAcheck resulted in the fewest acceptable urine collectionsacross all collections, 70-80% of 24-h urine collections were deemed usable. For approximately 10% of collections, participants reported at least one missed void. Very few participants selfreported missing more than one void (2-3 per collection). Table 2 shows the geometric mean of biomarker-based intakes of protein, protein density, potassium and potassium density by varying criteria of 24-h urine completeness. These values are generally in the direction expected: means for all biomarkers tend to decline with increasing liberalization of the exclusion criteria, but these declines are slight. Similarly, the coefficients of variation for protein and potassium slightly increase as inclusion becomes less conservative (Table 3) . Energy biomarker estimates of intake based on DLW were 2849 kcal for men and 2277 kcal for women. Table 4 shows how PABAcheck and 24-h urine completeness criteria affect estimated correlations with true intake and attenuation factors for FFQs and 24HRs. In general, different exclusion criteria have only a modest effect on these estimates.
The relationship between missed voids and PABAcheck is shown in Table 5 . Among all the 24-h urine collections for which no missed voids were self-reported, 76.2% were categorized as complete by PABAcheck. When participants not taking PABA pills were excluded, this increased to 84.1%. For 24-h urine collections for which 1 missed void was reported, 84.1% of all collections and 92.4% of collections excluding non-PABA-takers were deemed complete by PABAcheck. Nearly all collections among participants self-reporting not taking PABA were deemed incomplete by PABAcheck. Finally, mean levels of urinary nitrogen and potassium were nearly identical among those who reported taking and those who reported not taking PABA (data not shown).
Given the perceived difficulty in obtaining 24-h urine from study participants, these findings were unexpected, indicating that methods designed to confirm completeness either by PABAcheck or by self-reported missed voids had little effect on the overall descriptive and measurement error property findings for protein and potassium in the OPEN study. These results are similar to those found in another recent dietary measurement error substudy of the Women's Health Initiative. 8 The findings from both these studies provided a level of comfort with respect to combining 24-urinary nitrogen and potassium data from studies with and without PABAcheck. However, such findings do not necessarily indicate that PABAcheck or other measures of completeness should always be omitted from dietary biomarker studies. In OPEN, participants were informed that the purpose of PABA was to verify urine collection completeness. This, by itself, likely contributed to more complete collections. Importantly, the OPEN participants were particularly committed (once recruited, only two dropped out), highly educated, and not representative of the general population, 6 all of which likely contributed to complete collections. Additionally, the large sample size of OPEN appears to have afforded some ability to tolerate incomplete urine collections without meaningful consequences-a small metabolic study would likely not have this luxury.
Based on recent estimates, PABA pills are relatively inexpensive (approximately $9 per collection), but PABA analyses are not ($170 per collection). Given the costs, the obvious question from our Use of PABA to assess 24-h urine completeness AF Subar et al findings is whether using PABAcheck in a large-scale populationbased research is worthwhile. In the design of three new large biomarker studies currently in the field, the investigators decided, based on these findings, to provide PABA pills to all participants, informing them of their purpose but to not fund the PABA analyses at the outset of the study. Providing the PABA pills may aid in obtaining complete collections and will provide investigators a later opportunity to objectively measure completeness.
These findings indicate that the 93 urine collections among participants who opted not to take PABA and therefore were excluded by PABAcheck in the original analyses were usually complete. In light of these results, it appears that such exclusions were unnecessary. The question then arises as to whether it might be sufficient to trust the participants' self-report of missing voids. We found that a higher percentage of PABAcheck-complete urine was found among those reporting one missed void (92.4%) compared to those reporting no missed voids (84.1%). It is possible that those admitting to missing voids were, overall, more diligent or missed so little urine as to be inconsequential. However, urine collections for which participants reported missing 41 void were much more likely to be excluded by PABAcheck, indicating that self-reports of missing 41 void might be a useful threshold for determining exclusions in the absence of PABAcheck in certain populations.
Dr Sheila Bingham, our colleague and collaborator in the OPEN study, considered PABAcheck an imperative in the collection of Use of PABA to assess 24-h urine completeness AF Subar et al 24-h urine. It is difficult to disagree with this logic given the burden of urine collection. Therefore, the findings from this reanalysis of the OPEN study data were surprising. However, our findings by no means lead to the conclusion that PABAcheck is unnecessary. Rather, they suggest that it may not be necessary in a committed group of participants in OPEN-those willing to be dosed with DLW, provide blood and urine, attend three clinic visits and complete multiple dietary assessments. Diligence in collection of 24-h urine likely follows. This may not be true for other study populations. Until there are more analyses evaluating the necessity of PABAcheck, we recommend giving PABA pills to all participants, but not necessarily measuring it. Then, PABAcheck could be used selectively as a marker of completeness among urine collections in which low levels of biomarker are detected or for which non-compliance is suspected. 
